David A Chianese
Overview
Explore the profile of David A Chianese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paoletti C, Larios J, Muniz M, Aung K, Cannell E, Darga E, et al.
Mol Oncol
. 2016 May;
10(7):1078-85.
PMID: 27178224
Fulvestrant is a dose dependent selective estrogen receptor (ER) down-regulator (SERD) used in ER-positive metastatic breast cancer (MBC). Nearly all patients develop resistance. We performed molecular analysis of circulating tumor...
2.
Paoletti C, Muniz M, Thomas D, Griffith K, Kidwell K, Tokudome N, et al.
Clin Cancer Res
. 2014 Nov;
21(11):2487-98.
PMID: 25381338
Background: Endocrine therapy (ET) fails to induce a response in one half of patients with hormone receptor (HR)-positive metastatic breast cancer (MBC), and almost all will eventually become refractory to...
3.
Smerage J, Budd G, Doyle G, Brown M, Paoletti C, Muniz M, et al.
Mol Oncol
. 2013 Mar;
7(3):680-92.
PMID: 23538216
Background: Enumeration of circulating tumor cells (CTC) from whole blood permits monitoring of patients with breast carcinoma. Analysis of apoptosis & Bcl-2 expression in CTC might add additional prognostic and...